MolNFT v1 · #87064 · protein
Structure and substrate induced conformational changes of the secondary citrate-sodium symporter cits revealed by electron crystallography
4BPQ · CITRATE\:SODIUM symporter: “Structure and substrate induced conformational changes of the secondary citrate-sodium symporter cits…”. Electron crystallography, 10 pockets (best druggability 0.67). MolNFT v1 #87064 on GenesisL1: 3D…
- PDB
- 4BPQ
- Type
- protein
- Length
- 622 residues
- Chains
- 2
- Method
- electron crystallography
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- CITRATE\:SODIUM symporter
- Pockets
- 10 · best druggability 0.67
Structure
electron crystallography · 2 distinct chains · 90% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | CITRATE\:SODIUM symporter | protein | 304 | 90% helix, 0% strand | — |
| B | CITRATE\:SODIUM symporter | protein | 318 | 90% helix, 0% strand | — |
Pockets
10 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 785 | 0.67 | 0.74 | 115 | empty |
| 2 | 660 | 0.63 | 0.74 | 96 | empty |
| 3 | 257 | 0.48 | 0.73 | 40 | empty |
| 4 | 212 | 0.46 | 0.74 | 40 | empty |
| 5 | 122 | 0.41 | 0.76 | 22 | empty |
Interfaces
1 interface between chains.
- A–B · 765 Ų buried · 2 hydrogen bonds · protein-protein
Compared structures
- 4BPQ · Structure and substrate induced conformational changes of the secondary citrate-sodium… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 4BPQ · PDBe 4BPQ
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.